The global single blood drop analysis market was valued at USD 18,412.6 Million in 2019 and is projected to reach USD 43,921.5 Million by 2027, expanding at a CAGR of 11.5% during the forecast period. In terms of volume the single blood drop analysis market is anticipated to expand at a CAGR of 11.0% during the forecast period.
Request Free Sample Report Here
Single blood drop analysis is attained from a finger prick or capillary puncture method and is a source of a huge repository of biological data and information of patients. Single blood drop analysis technologies embrace the massive potential in PoC diagnostic technologies for detecting several levels of biomarkers, predominantly for the diagnosis and treatment of cancer. Growing need for accurate, rapid, and economical disease diagnostics in numerous clinical facilities is projected to propel the market. Increasing integration of such technologies in downstream molecular diagnosis is anticipated to significantly magnify the growth opportunities in the single blood drop analysis market. Large-scale developments in biotechnology and nanotechnology in the recent years are expected to create growth prospects in the market.
Generally, medical decisions depend upon the results of blood tests, meaning that accurate results are essential to offer information that can aid in the diagnosis, prevention, management, and treatment of diseases. The process becomes less painful with single blood drop technology, as small amount of blood is needed. Moreover, advanced technologies result in minimized human errors and costs associated with blood analysis. This, in turn, reduces the overall healthcare costs for individuals, which is anticipated to propel the single blood drop analysis market growth during the forecast period.
Market Dynamics
Growing healthcare spending, particularly in hospital settings, has increased focus in the direction of alternative methods of treatments such as home healthcare. This, in turn, fueled the demand for effective home-use devices with single blood drop analysis technologies.
Point-of-care (POC) testing allows medical staff and physicians to precisely receive lab-quality, real-time diagnostic results within minutes. Latest technological advancements have significantly increased the competencies of POC testing systems. Rapidly increasing demand for PoC settings in demographics with weak healthcare infrastructures is expected to create new opportunities for the key market participants.
Segmental Outlook
On the basis of type, the market is segmented into blood analyzers, consumables, and blood collection. In terms of value, the blood collection segment accounted for 31.9% share of the market in 2019. The rapid growth of the segment is attributed to the rise in the demand for the short time analysis of the blood drop. Capillary puncture blood collection method is widely used for infants or in adults where venipuncture is difficult which is anticipated to boost the segment growth during the forecast period.
In terms of application and services, the global single blood drop analysis market is divided into cancer, diabetics, cardiovascular, viral/bacterial infection, fertility, and allergy. According to the International Diabetes Federation (IDF) in 2019 over 463 million adults between the age of 20–79 years were living with diabetes. In terms of end-user, the global single blood drop analysis market is segregated into divided into hospitals, clinics, home, and others. The need for single blood drop analysis technology is rising in point-of-care (PoC) settings to diagnose the disease of patients at the earliest. The single blood drop technology is widely used in the diagnosis of diseases in pediatric patients, which in turn is projected to drive the growth of the hospital segment during the forecast period. Expanding role of such technologies in downstream molecular analysis is expected to substantially fuel the growth of the single blood drop analysis market.
Regional Outlook
In terms of regions, the global single blood drop analysis market is fragmented into Asia Pacific, Latin America, Europe, North America, and Middle East & Africa. In the terms of value, the market in the Asia Pacific is projected to expand at a CAGR of 12.1% during the forecast period. Rise in presence of several manufacturers, is thereby boosting the growth of the single blood drop analysis market in Asia Pacific.
About Growth Market Reports:
GROWTH MARKET REPORTS provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Industry Intelligence Solutions”. GROWTH MARKET REPORTS has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain. Our key analysis segments, though not restricted to the same, include market entry strategies, market size estimations, market trend analysis, market opportunity analysis, market threat analysis, market growth/fall forecasting, primary interviews, secondary research & consumer surveys.
Contact:
Growth Market Reports
Phone: +1 909 414 1393
Email: sales@growthmarketreports.com
Web: https://growthmarketreports.com
